Landscapes / Targets
S1PR
5 drugs act on S1PR, in 9 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs5
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Sphingosine 1-phosphate receptor modulator |
Vanda Pharmaceuticals +1 |
Approved | Aug 2028Phase 3 trial completes | ||
| Next date | Aug 2028 · Phase 3 trial completes | ||||
| Also tested for | Moderate-to-severe Chronic Plaque Psoriasis, Ulcerative Colitis (UC) | ||||
| Open drug page | |||||
Sphingosine 1-phosphate receptor modulator |
Approved | 29 Dec 2028Phase 4 trial completes | |||
| Next date | 29 Dec 2028 · Phase 4 trial completes | ||||
| Also tested for | Colitis, Ulcerative, Relapsing Multiple Sclerosis and 1 more | ||||
| Open drug page | |||||
Sphingosine 1-phosphate receptor modulator |
Novartis · Public NVS |
Approved | — | ||
| Also tested for | Multiple Sclerosis, Multiple Sclerosis (MS) | ||||
| Open drug page | |||||
Sphingosine 1-phosphate receptor modulator |
Novartis · Public NVS |
Approved | — | ||
| Also tested for | Multiple Sclerosis (MS) | ||||
| Open drug page | |||||
— |
Phase 3 | May 2027Phase 3 trial completes | |||
| Next date | May 2027 · Phase 3 trial completes | ||||
| Also tested for | Adult Acute Myeloid Leukemia | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 5 of 5 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026